Navigation Links
Arpida Presents Data on Iclaprim at Scientific Congress in Germany
Date:11/2/2007

-drug resistant bacteria, including MRSA. We feel iclaprim could in the future play an important role in combating life-threatening infections caused by 'the superbug'."

The Phase I data presented in Kiel will be part of the NDA package that is expected to be submitted to the US Food and Drug Administration in the course of this year. Overall, the clinical programmes with iclaprim and the path towards the NDA filing for intravenous iclaprim in its first indication are on track. Patient enrolment into the Phase II studies with intravenous iclaprim in its second indication (HAP/VAP/HCAP) as well as into the Phase III trial with the TLT therapy in onychomycosis is expected to get underway shortly.

Arpida has a comfortable cash position, with cash and financial investments of CHF 95 million at the end of June 2007.

Arpida plans to give further updates on the progress of intravenous and oral iclaprim as well as TLT in the course of this year.

About Arpida Ltd.

Arpida (SWX: ARPN) is a biopharmaceutical company with research facilities near Basel, Switzerland and in the USA. It focuses on the discovery and development of novel drugs that seek to overcome the growing problem of microbial resistance. The most advanced compounds include an antibacterial close to NDA-filing and an antifungal in Phase III.

Arpida's leading product candidate is intravenous iclaprim, a potent, pathogen-focused, late-stage antibiotic that targets severe infections requiring hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). The US Food and Drug Administration has granted fast track status to intravenous iclaprim. In March 2007, Arpida completed patient enrolment in the second pivotal Phase III trial in complicated skin and skin structure infections. The top-line data of the second trial were reported in July 2007. An NDA filing is expected to take place in the second half of 2007.

In June 2007, Arpida announce
'/>"/>

SOURCE Arpida Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NimbleGen presents new tech for comparing microbe DNA
2. Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
3. Thieme Presents Unique Technology Angle at Gov.s Conference
4. UW-Madisons Beebe wins scientific award
5. Researchers say scientific reporting needs more perspective, less hype
6. Wisconsin stands at the center of scientific efforts to avert flu epidemics
7. Growth prompts new location for scientific instrument manufacturer
8. UW stem cell guru outlines scientific and political future
9. Wisconsin biotech sector featured in scientific magazine
10. Scientific Protein Laboratories Acquired by New York firm
11. GenTel Appoints Burke to its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... (PRWEB) March 02, 2015 ... newly formed alliance with Shenzhen HANK Bioengineering Co., ... Ph.D. The alliance will establish a stem cells ... Province, China in September 2015. , Shenzhen HANK ... Zhang, an award-winning scientist, microbiologist and virologist, to ...
(Date:3/1/2015)... UK (PRWEB) March 01, 2015 ... partnership agreement for quality market research promotion on ... sell research reports worked out by DataGroup Booksellers. ... at Market Publishers Ltd, commented on the recent ... have DataGroup Booksellers in our team of publishers. ...
(Date:2/27/2015)... Nova Scotia (PRWEB) February 27, 2015 ... been made aware of a fraudulent press release disseminated ... purporting to be from Immunovaccine. This press release states ... Gilead Science, Inc. The press release did not ... the information contained within the press release. Please ...
(Date:2/27/2015)... , Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... toxicology studies for its newly developed Bruton,s tyrosine ... have been completed. The results of these preclinical ... and Drug Administration. The feedback received from the ... ongoing first-in-human study. Additional preclinical work is required ...
Breaking Biology Technology:Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3Immunovaccine Disclaims Hoax Press Release 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3
... Collaboration Expected to Drive Physician Adoption of Patient-Safety ... ... Physician Portal Lab Order ... Incorporated (NYSE: DGX ), the nation,s leading provider of,diagnostic testing, information ...
... Amarin Corporation plc,(NASDAQ: AMRN ) today announced ... 4th Annual Bio Investor Forum on Wednesday, October 10,2007 ... held from October 9 to 11,at the Palace Hotel, ... and a link will be,provided on Amarin Corporation,s website ...
... homegrown New Jersey company is,earning accolades for its ... Secure Symbology, (http://www.securesymbology.com ), a Wayne, NJ based ... Emerging Business of the Year by NJBiz Magazine. ... wipe out counterfeit drugs,worldwide. (Logo: http://www.newscom.com/cgi-bin/prnh/20070530/NEW056LOGO ...
Cached Biology Technology:Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI) 2Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI) 3Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI) 4Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI) 5Amarin to Present at 4th Annual Bio Investor Forum 2Amarin to Present at 4th Annual Bio Investor Forum 3Secure Symbology: Making New Jersey Proud While Saving Lives 2
(Date:2/5/2015)... Calif. , Feb. 3, 2015 ... technology, demand from industries such as consumer electronics, ... market for surface mount technology (SMT) screen printers. ... to automatic control will push the adoption curve ... will remain steady as glue dispensers are indispensable ...
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... proteins, known as transcription factors, directly control the way ... a result, it is widely believed that changes in ... evolutionary adaptation. The idea that small RNA molecules, ... changes to animals, appearance is completely new. An ...
... advances in agronomy, breeding, and biotechnology have dramatically ... that producers may not be supplying optimal nutrient ... ago using outdated agronomic management practices and lower-yielding, ... with the University of Illinois Crop Physiology Laboratory ...
... group at the Bellvitge Biomedical Research Institute (IDIBELL) and ... and structural study of seven missense variants of the ... pathogenic, linked to the risk of suffering breast or ... journal PLoS One The classification of ...
Cached Biology News:A surprising new function for small RNAs in evolution 2Fertility needs in high-yielding corn production 2Fertility needs in high-yielding corn production 3Identified as responsible for breast and ovarian hereditary cancer 3 mutations at BRCA1 gene 2
... Kinase (PNK) catalyzes the transfer of ... 5'-hydroxyl of single- and double-stranded DNA, ... also removes the 3'-phosphate from 3'-phosphoryl ... 5'-diphosphates to form a 3'-hydroxyl group. ...
The Cellject Elecroporator is suitable for all cell types including embryo, mammalian, plant, yeast and bacterial. Its has highly user-freindly programing and can be used remotely, for example in a l...
Request Info...
... Myeloblastosis Virus Reverse Transcriptase (AMV RT) catalyzes ... RNA or RNA:DNA hybrids (1). It requires ... than RNA primers) as well as Mg2+ ... RNase H activity. Both nonionic detergents and ...
Biology Products: